IP Library Granted Patent US 10,850,091
Granted Patent B2
US 10,850,091 · App. 16/211,142 · Granted Dec 1, 2020

Methods and apparatus for bilateral renal neuromodulation

Inventors: Denise Zarins (Saratoga, CA); Hanson Gifford, III (Woodside, CA); Mark Deem (Mountain View, CA); Douglas Sutton (Pacifica, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61N1/0551A61B18/12A61B18/14A61B18/1492A61M5/1408A61M5/14276A61N1/0412A61N1/05A61N1/327A61N1/36007A61N1/36017A61B2018/00267A61B2018/00351A61B2018/00404A61B2018/00434A61B2018/00511A61B2018/00577A61B2018/00613A61M2210/1082A61N7/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,850,091
App. No.
16/211,142
Granted
Dec 1, 2020
Kind
B2
Abstract

Methods and apparatus are provided for bilateral renal neuromodulation, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

Claims (27)

1. A method, comprising:

positioning a first expandable element of a first catheter within a first renal artery of a hypertensive human patient and adjacent to first neural fibers innervating a first kidney of the patient;

transforming the first expandable element from a reduced profile configuration to an, expanded configuration;

delivering first ultrasound energy from the first catheter to the first neural fibers, wherein the first ultrasound energy is sufficient to at least partially ablate the first neural fibers;

positioning a second expandable element of a second catheter within a second renal artery of the patient and adjacent to second neural fibers innervating a second kidney of the patient;

transforming the second expandable element from a reduced profile configuration to an expanded configuration; and

delivering second ultrasound energy from the second catheter to the second neural fibers, wherein the second ultrasound energy is sufficient to at least partially ablate the second neural fibers,

wherein at least partially ablating the first neural fibers and the second neural fibers results in a therapeutically beneficial reduction in blood pressure of the patient.

2. The method of claim 1 wherein at least partially ablating the first neural fibers and the second neural fibers results further results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient.

3. The method of claim 1 , further comprising transforming the first expandable element from the expanded configuration to the reduced profile configuration and removing the first catheter from the patient before positioning the second catheter within the second renal artery of the patient.

4. The method of claim 1 , further comprising removing the first and second catheters from the patient after delivering the first and second ultrasound energy to conclude the procedure.

5. The method of claim 1 wherein:

positioning a first expandable element of a first catheter within a first renal artery of a hypertensive human patient comprises intravascularly delivering the first expandable element of the first catheter over a first guidewire to the first renal artery; and

positioning a second expandable element of a second catheter within a second renal artery of the patient comprises intravascularly delivering the second expandable element of the second catheter over a second guidewire to the second renal artery.

6. The method of claim 1 wherein the first ultrasound energy is different from the second ultrasound energy.

7. The method of claim 1 wherein the first ultrasound energy is the same as the second ultrasound energy.

8. The method of claim 1 wherein the first ultrasound energy and the second ultrasound energy are both high frequency ultrasound energy.

9. The method of claim 1 wherein positioning a first expandable element of a first catheter within a first renal artery and positioning a second expandable element of a second catheter within a second renal artery occurs simultaneously.

10. The method of claim 1 wherein positioning a first expandable element of a first catheter within a first renal artery and positioning a second expandable element of a second catheter within a second renal artery occur sequentially.

11. The method of claim 1 wherein:

delivering first ultrasound energy from the first catheter to the first neural fibers further comprises reducing renal sympathetic nerve activity of the first kidney; and

delivering second ultrasound energy from the second catheter to the second neural fibers further comprises reducing renal sympathetic nerve activity of the second kidney.

12. The method of claim 1 wherein, in the expanded configurations, the first expandable element occludes blood flow in the first renal artery and the second expandable element occludes blood flow in the second renal artery.

13. The method of claim 1 , further comprising monitoring a parameter of target tissue and/or non-target tissue within the patient before and during first and second ultrasound energy delivery.

14. Me method of claim 13 wherein monitoring a parameter comprises monitoring temperature of target tissue.

15. The method of claim 13 , further comprising altering first and/or second ultrasound energy delivery in response to the monitored parameter.

16. The method of claim 13 , further comprising adjusting a treatment parameter in response to the monitoring.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2019
From: DEMARAIS, DENISE; GIFFORD, HANSON, III; DEEM, MARK; SUTTON, DOUGLAS; LEVIN, HOWARD R.; GELFAND, MARK
To: ARDIAN, INC.
Reel/Frame 048112/0869 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2019
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 048113/0004 →
CHANGE OF NAME Recorded Jan 23, 2019
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 049167/0093 →
Continuity (27)
Continuation 15729326 · Oct 10, 2017
Continuation 15269010 · Sep 19, 2016
Continuation 14816115 · Aug 3, 2015
Continuation 14260060 · Apr 23, 2014
Continuation 14034434 · Sep 23, 2013
Continuation 13361685 · Jan 30, 2012
Division 11368836 · Mar 6, 2006
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11133925 · May 20, 2005
Continuation 10900199 · Jul 28, 2004
Continuation In Part 10408665
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 11266993 · Nov 4, 2005
Continuation In Part 11363867 · Feb 27, 2006
Continuation In Part 11189563
Continuation In Part 11266993
Continuation In Part 11129765
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60813589 · Dec 29, 2005
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Related Publication 20190175903A1 · Jun 13, 2019
Cited By (14)
US 12,274,833 US 12,336,753 US 12,349,928 US 12,350,050 US 12,419,662 US 12,440,165 US 12,496,089 US 12,527,494 US 12,594,185 US 12,594,405 US 12,636,470 US 12,653,559 US 12,661,032 US 12,685,585